EGALET CORPORATION, as Issuer, the Guarantors party hereto as of the date hereof and any Guarantor that becomes party hereto pursuant to Section 4.10 hereof 13% Senior Secured Notes due 2024Supplemental Indenture • February 1st, 2019 • Egalet Corp • Pharmaceutical preparations • New York
INDENTURE dated as of January 31, 2019 among Egalet Corporation, a Delaware corporation with an address at 600 Lee Road, Suite 100, Wayne, Pennsylvania 19087 (the “Issuer”), the Guarantors party hereto as of the date hereof, any other Guarantor that becomes party hereto pursuant to Section 4.10, and U.S. Bank National Association, as trustee (as more fully defined in Section 1.01, the “Trustee”) and as collateral agent (as more fully defined in Section 1.01, the “Collateral Agent”).
FORM OF COMMON STOCK PURCHASE WARRANT(1) EGALET CORPORATIONCommon Stock Purchase Warrant • February 1st, 2019 • Egalet Corp • Pharmaceutical preparations • Delaware
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time and from time to time after the date hereof (the “Initial Exercise Date”), to subscribe for and purchase from Egalet Corporation, a Delaware corporation (the “Company”), [ ] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
STOCKHOLDERS’ AGREEMENTStockholders’ Agreement • February 1st, 2019 • Egalet Corp • Pharmaceutical preparations • Delaware
This STOCKHOLDERS’ AGREEMENT (this “Agreement”), dated as of January 31, 2019 (the “Effective Date”), is by and among Egalet Corporation, a Delaware corporation (the “Corporation”), and each of the Stockholders (as defined below) signatory hereto.
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • February 1st, 2019 • Egalet Corp • Pharmaceutical preparations • Delaware
This AMENDMENT (this “Amendment”), effective as of 12:01 a.m. [February 1], 2019, is entered into, consented to and approved by the undersigned individual, in his or her capacity as the Executive, and Egalet Corporation, a Delaware corporation (the “Company”), pursuant to and in accordance with Sections [12(a) and 12(h)] of that certain Employment Agreement, made and entered into as of [·], by and between the Company and the Executive (the “Agreement”).
